These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Strong inhibition of cholera toxin by multivalent GM1 derivatives. Pukin AV; Branderhorst HM; Sisu C; Weijers CA; Gilbert M; Liskamp RM; Visser GM; Zuilhof H; Pieters RJ Chembiochem; 2007 Sep; 8(13):1500-3. PubMed ID: 17625801 [No Abstract] [Full Text] [Related]
7. Characterization of the binding of cholera toxin to ganglioside GM1 immobilized onto microtitre plates. Dawson RM J Appl Toxicol; 2005; 25(1):30-8. PubMed ID: 15669043 [TBL] [Abstract][Full Text] [Related]
8. Crystal structure of cholera toxin B-pentamer bound to receptor GM1 pentasaccharide. Merritt EA; Sarfaty S; van den Akker F; L'Hoir C; Martial JA; Hol WG Protein Sci; 1994 Feb; 3(2):166-75. PubMed ID: 8003954 [TBL] [Abstract][Full Text] [Related]
9. Effects of polymer structure on the inhibition of cholera toxin by linear polypeptide-based glycopolymers. Polizzotti BD; Kiick KL Biomacromolecules; 2006 Feb; 7(2):483-90. PubMed ID: 16471920 [TBL] [Abstract][Full Text] [Related]
10. Natural and synthetic cholera toxin antagonists. Velter IA; Politi M; Podlipnik C; Nicotra F Mini Rev Med Chem; 2007 Feb; 7(2):159-70. PubMed ID: 17305590 [TBL] [Abstract][Full Text] [Related]
11. Cholera Toxin Encapsulated within Several Rasti ES; Brown AC Toxins (Basel); 2019 Apr; 11(4):. PubMed ID: 30959895 [TBL] [Abstract][Full Text] [Related]
12. Inhibition by apple polyphenols of ADP-ribosyltransferase activity of cholera toxin and toxin-induced fluid accumulation in mice. Saito T; Miyake M; Toba M; Okamatsu H; Shimizu S; Noda M Microbiol Immunol; 2002; 46(4):249-55. PubMed ID: 12061627 [TBL] [Abstract][Full Text] [Related]
13. Cholera intoxication of human enteroids reveals interplay between decoy and functional glycoconjugate ligands. Singla A; Boucher A; Wallom KL; Lebens M; Kohler JJ; Platt FM; Yrlid U Glycobiology; 2023 Oct; 33(10):801-816. PubMed ID: 37622990 [TBL] [Abstract][Full Text] [Related]
14. Novel GM1 ganglioside-like peptide mimics prevent the association of cholera toxin to human intestinal epithelial cells in vitro. Yu RK; Usuki S; Itokazu Y; Wu HC Glycobiology; 2016 Jan; 26(1):63-73. PubMed ID: 26405107 [TBL] [Abstract][Full Text] [Related]
15. Fluorescence analysis of galactose, lactose, and fucose interaction with the cholera toxin B subunit. Mertz JA; McCann JA; Picking WD Biochem Biophys Res Commun; 1996 Sep; 226(1):140-4. PubMed ID: 8806604 [TBL] [Abstract][Full Text] [Related]
16. Picomolar inhibition of cholera toxin by a pentavalent ganglioside GM1os-calix[5]arene. Garcia-Hartjes J; Bernardi S; Weijers CA; Wennekes T; Gilbert M; Sansone F; Casnati A; Zuilhof H Org Biomol Chem; 2013 Jul; 11(26):4340-9. PubMed ID: 23689250 [TBL] [Abstract][Full Text] [Related]
17. Novel Cholera Toxin Variant and ToxT Regulon in Environmental Neogi SB; Chowdhury N; Awasthi SP; Asakura M; Okuno K; Mahmud ZH; Islam MS; Hinenoya A; Nair GB; Yamasaki S Appl Environ Microbiol; 2019 Feb; 85(3):. PubMed ID: 30446560 [TBL] [Abstract][Full Text] [Related]
18. Manipulation of electrostatic and saccharide linker interactions in the design of efficient glycopolypeptide-based cholera toxin inhibitors. Maheshwari R; Levenson EA; Kiick KL Macromol Biosci; 2010 Jan; 10(1):68-81. PubMed ID: 19780061 [TBL] [Abstract][Full Text] [Related]